Safety of pembrolizumab in combination with bevacizumab in recurrent glioblastoma (rGBM).

被引：13
|
作者：
Reardon, David A.
De Groot, John Frederick
Colman, Howard
Jordan, Justin T.
Daras, Mariza
Clarke, Jennifer Leigh
Nghiemphu, Phioanh Leia
Gaffey, Sarah C.
Peters, Katherine B.
机构：
[1] Harvard Canc Ctr, Dana Farber Canc Inst, Boston, MA USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Hunstman Canc Inst Utah, Salt Lake City, UT USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[6] Univ Calif San Francisco, San Francisco, CA 94143 USA
[7] Univ Calif Los Angeles, Los Angeles, CA USA
[8] Dana Farber Canc Inst, Boston, MA 02115 USA
[9] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.2010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2010
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase II study of pembrolizumab or pembrolizumab plus bevacizumab for recurrent glioblastoma (rGBM) patients
    Reardon, David A.
    Nayak, Lakshmi
    Peters, Katherine B.
    Clarke, Jennifer Leigh
    Jordan, Justin T.
    De Groot, John Frederick
    Nghiemphu, Phioanh Leia
    Kaley, Thomas Joseph
    Colman, Howard
    Gaffey, Sarah C.
    Caruso, Victoria
    Debruyne, Myriam Bednarek
    Bhavsar, Chinmay
    Molinaro, Annette M.
    Smith, Timothy
    Severgnini, Mariano
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] NCCTG PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH SORAFENIB (BEV/SOR) IN RECURRENT GLIOBLASTOMA (rGBM)
    Galanis, Evanthia
    Anderson, S. Keith
    Lafky, Jacqueline M.
    Kaufmann, Timothy J.
    Uhm, Joon H.
    Giannini, Caterina
    Kumar, Shaji K.
    Northfelt, Donald W.
    Flynn, Patrick J.
    Jaeckle, Kurt A.
    Buckner, Jan C.
    NEURO-ONCOLOGY, 2011, 13 : 62 - 62
  • [3] Phase Ib study of olinvacimab (O) with pembrolizumab (P) in patients with recurrent glioblastoma (rGBM).
    Nowak, Anna K.
    Cher, Lawrence
    Bowyer, Samantha
    Gan, Hui Kong
    Long, Anne Poh
    Balasubramanian, Adithya
    Lee, Seon Young
    Lee, Weon Sup
    Yoo, Jin-San
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
    Friedman, Henry S.
    Prados, Michael D.
    Wen, Patrick Y.
    Mikkelsen, Tom
    Schiff, David
    Abrey, Lauren E.
    Yung, W. K. Alfred
    Paleologos, Nina
    Nicholas, Martin K.
    Jensen, Randy
    Vredenburgh, James
    Huang, Jane
    Zheng, Maoxia
    Cloughesy, Timothy
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) : 4733 - 4740
  • [5] Case report: The effective response to pembrolizumab in combination with bevacizumab in the treatment of a recurrent glioblastoma with multiple extracranial metastases
    Yang, Gang
    Fang, Yu
    Zhou, Ming
    Li, Wei
    Dong, Dapeng
    Chen, Jing
    Da, Yong
    Wang, Kunpeng
    Li, Xinru
    Zhang, Xiaoyan
    Ma, Tonghui
    Shen, Ge
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS
    Reardon, David
    Molinaro, Annette
    Peters, Katherine
    Clarke, Jennifer
    Jordan, Justin
    de Groot, John
    Nghiemphu, Phioanh
    Kaley, Thomas
    Colman, Howard
    McCluskey, Christine
    Smith, Timothy
    Cote, David
    Severgnini, Mariano
    Yearley, Jennifer
    Zhao, Qing
    Blumenschein, Wendy
    Duda, Gabriel
    Muzikansky, Alona
    Jain, Rakesh
    Wen, Patrick
    Nayak, Lakshmi
    NEURO-ONCOLOGY, 2020, 22 : 40 - 40
  • [7] LUMINOS-101: INITIAL SAFETY AND TOLERABILITY OF PVSRIPO AND PEMBROLIZUMAB COMBINATION THERAPY IN RECURRENT GLIOBLASTOMA
    Sloan, Andrew
    Buerki, Robin
    Landi, Daniel
    Desjardins, Annick
    Friedman, Allan
    Ambady, Prakash
    Becker, Kevin
    Butowski, Nicholas
    Cavaliere, Robert
    Curry, William
    Ong, Shirley
    Vega, Rafael
    Wen, Patrick
    Bockorny, Bruno
    Chiocca, E. Antonio
    Elder, J. Bradley
    Bulsara, Ketan
    Berger, Mitchel
    Gerstner, Elizabeth
    Sauvageau, Eric
    Kelly, Andrea
    Mixson, Lori
    Jackson, Leann
    Learn, Chris
    Dickinson, Adam
    Nichols, W. Garrett
    NEURO-ONCOLOGY, 2021, 23 : 53 - 54
  • [8] Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme
    Schiff, David
    Purow, Benjamin
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (04): : 186 - 187
  • [9] Panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic ghouls
    Lee, Eudocia Quant
    Reardon, David A.
    Schiff, David
    Drappatz, Jan
    Muzlkansky, Alona
    Grimm, Sean Aaron
    Norden, Andrew David
    Nayak, Lakshmi
    Beroukhim, Rameen
    Rinne, Mikael L.
    Chi, Andrew S.
    Batchelor, Tracy
    Hempfling, Kelly
    McCluskey, Christine Sceppa
    Smith, Katrina H.
    Gaffey, Sarah C.
    Wrigley, Brendan
    Ralzer, Jeffrey J.
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme
    David Schiff
    Benjamin Purow
    Nature Clinical Practice Oncology, 2008, 5 : 186 - 187
12345